| RS2545423875 |
GUCY2D
|
Health Risk |
Likely pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS2545423946 |
GUCY2D
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 1, Cone-rod dystrophy 6 |
| RS2545423955 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS2545423992 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS2545424362 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS2545424818 |
GUCY2D
|
Health Risk |
Likely pathogenic |
Autosomal recessive optic atrophy, Autosomal recessive optic atrophy |
| RS2545425310 |
GUCY2D
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 1, Cone-rod dystrophy 6 |
| RS2545425374 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS2545426022 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS2545426279 |
GUCY2D
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 1, Cone-rod dystrophy 6 |
| RS2545426334 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS2545426389 |
GUCY2D
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 1, Cone-rod dystrophy 6 |
| RS2545426444 |
GUCY2D
|
Health Risk |
Likely pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS2545426712 |
GUCY2D
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 1, Cone-rod dystrophy 6 |
| RS2545427510 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS2545427548 |
DYSF
|
Health Risk |
Likely pathogenic |
— |
| RS2545427576 |
GUCY2D
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 1, Cone-rod dystrophy 6 |
| RS2545427768 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545427870 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545427980 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545428060 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2545428157 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2545431362 |
ABCB11
|
Health Risk |
Pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545431676 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545432219 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2545432299 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2545432325 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545437087 |
SRD5A3
|
Health Risk |
Pathogenic |
SRD5A3-congenital disorder of glycosylation, SRD5A3-congenital disorder of glycosylation |
| RS2545439344 |
CFI
|
Health Risk |
Pathogenic/Likely pathogenic, low penetrance |
CFI-related disorder, CFI-related disorder |
| RS2545442155 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545442611 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545450042 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 1 |
| RS2545450310 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545450430 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545450572 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545450648 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545450715 |
ABCB11
|
Health Risk |
Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545453446 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545453686 |
ABCB11
|
Health Risk |
Pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545453932 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Miyoshi muscular dystrophy 1 |
| RS2545453964 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545455816 |
SRD5A3
|
Health Risk |
Likely pathogenic |
SRD5A3-related disorder, SRD5A3-related disorder |
| RS2545456303 |
CFI
|
Health Risk |
Pathogenic |
— |
| RS2545456977 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545456988 |
CFI
|
Health Risk |
Pathogenic |
— |
| RS2545457176 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545457223 |
CFI
|
Health Risk |
Pathogenic |
— |
| RS2545457659 |
CFI
|
Health Risk |
Pathogenic |
Atypical hemolytic-uremic syndrome with I factor anomaly, Atypical hemolytic-uremic syndrome with I factor anomaly |
| RS2545457733 |
BRIP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2545458344 |
BRIP1
|
Health Risk |
Pathogenic |
Gastric cancer, Gastric cancer |
| RS2545458587 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545459007 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2545459291 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2545459688 |
DYSF
|
Health Risk |
Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545459725 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545459997 |
SETD2
|
Health Risk |
Pathogenic |
Luscan-Lumish syndrome, Luscan-Lumish syndrome |
| RS2545460283 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545460807 |
SPEG
|
Health Risk |
Likely pathogenic |
SPEG-related congenital myopathy, SPEG-related congenital myopathy |
| RS2545460919 |
BRIP1
|
Health Risk |
Pathogenic |
Gastric cancer, Gastric cancer |
| RS2545461593 |
ADGRG1
|
Health Risk |
Pathogenic |
— |
| RS2545466822 |
ADGRG1
|
Health Risk |
Pathogenic |
Bilateral frontoparietal polymicrogyria, Bilateral frontoparietal polymicrogyria |
| RS2545469146 |
ADGRG1
|
Health Risk |
Pathogenic |
— |
| RS2545471112 |
BRIP1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2545471484 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545471798 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545471956 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545472337 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2545472660 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545472704 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2545472842 |
BRIP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2545472874 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2545473289 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545473339 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545473484 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545474992 |
TRIM37
|
Health Risk |
Pathogenic |
— |
| RS2545475168 |
SPEG
|
Health Risk |
Pathogenic |
— |
| RS2545475792 |
TRIM37
|
Health Risk |
Likely pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS2545476369 |
TRIM37
|
Health Risk |
Likely pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS2545479555 |
BRIP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2545479728 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545480017 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS2545480384 |
BRIP1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545480492 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2545480564 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2545480859 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545480911 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2545484647 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2545484771 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545485020 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2545485145 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545485149 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2545485315 |
ABCB11
|
Health Risk |
Likely pathogenic |
— |
| RS2545487249 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545487369 |
ABCB11
|
Health Risk |
Likely pathogenic |
Progressive familial intrahepatic cholestasis, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545491327 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545491426 |
ABCB11
|
Health Risk |
Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545491594 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545491750 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545492134 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545492351 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Distal myopathy with anterior tibial onset |